15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 8 firms covering ESAB Corp, 8 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $130.00 to $151.00, so the covering firms are broadly aligned. The average target of $138.38 sits 55% above the current $89.10. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees revenue growth near 7% this year and 5% next, consensus EPS building from about $1.47 next quarter toward $6.67 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS8 ratings
Moderate Buy
Strong Buy00%
Buy8100%
Hold00%
Sell00%
Strong Sell00%
Based on 8 analysts giving stock ratings to ESAB Corp.
As of Jul, 8 of 8 firms rate ESAB a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
ESAB EPS & revenue forecast
EPS · NEXT QUARTER
$1.47
Range $1.39 – $1.51 · 8 analysts · +11% YoY
Next period, 8 analysts expect ESAB Corp to earn $1.47 a share (range $1.39 – $1.51), versus $1.32 a year earlier. Full-year consensus is $5.70, growing to $6.67 the year after.
REVENUE · NEXT QUARTER
$788.2M
Range $726.4M – $801.0M · 8 analysts · +9% YoY
Revenue is expected to reach $788.2M (range $726.4M – $801.0M), +9.0% year-over-year. Full-year consensus is $3.0B, rising to $3.3B next year.
Top analysts covering ESAB Corp
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ESAB.
#1
Nathan Jones
Stifel · Rank #102
Buy
$137.00+53.8% to target
Overall win rate
49%
+ Follow
#2
Tami Zakaria
JP Morgan
Buy
$135.00+51.5% to target
Coverage
—
+ Follow
#3
NB
Neal Burk
UBS
Buy
$149.00+67.2% to target
Coverage
—
+ Follow
#4
Bryan Blair
Oppenheimer
Buy
$135.00+51.5% to target
Coverage
—
+ Follow
#5
Stephen Volkmann
Jefferies
Buy
$130.00+45.9% to target
Coverage
—
+ Follow
ESAB stock forecast FAQ
What is ESAB's average 12-month price target?+
The 8 analysts with a live target average $138.38 for ESAB Corp over the next 12 months, ranging from a $151.00 high to a $130.00 low.
Is ESAB stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 8 analyst ratings, 8 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for ESAB?+
The Street-high target is $151.00 (Roth Capital), and the Street-low is $130.00 (DA Davidson). The average of all 8 active targets is $138.38.
How many Wall Street analysts cover ESAB?+
8 analysts have an active rating on ESAB Corp, and 8 firms carry a live 12-month price target.
Who is the most accurate analyst covering ESAB?+
Among analysts who currently cover ESAB, Nathan Jones of Stifel has the strongest overall Quantellect track record (Rank #102). Their current call is Buy with a $137.00 target.
What is ESAB Corp's projected EPS for next quarter?+
The consensus estimate is $1.47 per share (range $1.39 – $1.51) across 8 analysts. Full-year EPS is projected at $5.70, rising to $6.67 the following year.
How much revenue is ESAB Corp expected to report next quarter?+
Consensus revenue is $788.2M (range $726.4M – $801.0M). Full-year revenue is projected at $3.0B, growing to $3.3B next year.
Have analysts been upgrading or downgrading ESAB lately?+
As of Jul, 8 of 8 firms rate ESAB a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ESAB calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
